孕前母体脂蛋白水平与生育力的关系
该研究为EAGeR试验的二次分析,纳入1228名有1-2次妊娠丢失史、无不孕诊断、尝试妊娠至多6个月经周期的女性,在治疗随机化前测量基线血脂。结果显示,总胆固醇、LDL-C、HDL-C和甘油三酯任一异常均与生育力降低相关,但校正中心性肥胖和BMI后关联减弱。
要点
- 总胆固醇≥200 mg/dl与hCG检测妊娠的生育力比值比FOR 0.76(95% CI 0.59, 0.97)相关。
- 总胆固醇≥200 mg/dl与超声确认妊娠的FOR 0.71(95% CI 0.55, 0.93)相关。
- 脂蛋白异常女性每个周期受孕概率降低19-36%,但校正中心性肥胖和BMI后关联减弱。
核心结论
- 所有异常女性血脂水平(总胆固醇、LDL-C、HDL-C和总甘油三酯)均与生育力降低相关。
- 脂蛋白异常女性每个周期受孕概率降低19-36%,但校正中心性肥胖和BMI后观察到的关联减弱。
- 脂质水平可改变,可能作为改善女性生育力的低成本靶点。
研究设计与样本
- EAGeR试验(2007-2011)的二次分析,该试验为区组随机、双盲、安慰剂对照试验。
- 共纳入1228名女性,有1-2次既往妊娠丢失且无不孕诊断,尝试妊娠至多6个月经周期,从犹他州、纽约州、宾夕法尼亚州和科罗拉多州的临床中心招募。
- 在治疗随机化前测量基线个体孕前脂蛋白水平,并按临床常用切点二分类:总胆固醇≥200 mg/dl、LDL-C≥130 mg/dl、HDL-C<50 mg/dl、甘油三酯≥150 mg/dl。
主要发现
- 总胆固醇升高者148例(12.3%),LDL-C升高者94例(7.9%),甘油三酯升高者280例(23.2%),HDL-C降低者606例(50.7%)。
- 总胆固醇≥200 mg/dl与hCG检测妊娠的FOR 0.76(95% CI 0.59, 0.97)相关,与超声确认妊娠的FOR 0.71(95% CI 0.55, 0.93)相关,均较总胆固醇<200 mg/dl组生育力降低。
- 所有异常血脂在校正混杂因素前后FOR均降低,表明生育力降低;但进一步校正中心性肥胖和BMI后关联减弱。
关键数值与推荐
- 总胆固醇≥200 mg/dl与hCG检测妊娠的FOR 0.76(95% CI 0.59, 0.97),与超声确认妊娠的FOR 0.71(95% CI 0.55, 0.93),均以总胆固醇<200 mg/dl为参照。
- 脂蛋白异常女性每个周期受孕概率降低19-36%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 尽管FOR是夫妇生育力的测量指标,但本研究仅测量女性血脂水平,因此无法证实既往研究提示的男性血脂在生育力中的独立作用。
- 校正中心性肥胖和肥胖后估计值减弱且精度下降,表明潜在因果脂质通路的复杂性,提示除血脂异常外与肥胖相关的其他因素可能促成生育力降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are maternal preconception lipid levels associated with fecundability? SUMMARY ANSWER: Fecundability was reduced for all abnormal female lipid levels including total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and total triglyceride levels. WHAT IS KNOWN ALREADY: Subfecundity affects 7-15% of the population and lipid disorders are hypothesized to play a role since cholesterol acts as a substrate for the synthesis of steroid hormones. Evidence illustrating this relationship at the mechanistic level is mounting but few studies in humans have explored the role of preconception lipids in fecundity. STUDY DESIGN, SIZE, DURATION: A secondary analysis of the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial (2007-2011), a block-randomized, double-blind, placebo-controlled trial. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 1228 women, with 1-2 prior pregnancy losses and without a diagnosis of infertility, attempting pregnancy for up to six menstrual cycles were recruited from clinical sites in Utah, New York, PA and Colorado. Time to pregnancy was the number of menstrual cycles to pregnancy as determined by positive hCG test or ultrasound. Individual preconception lipoproteins were measured at baseline, prior to treatment randomization and dichotomized based on clinically accepted cut-points as total cholesterol ≥200 mg/dl, LDL-C ≥130 mg/dl, HDL-C <50 mg/dl and triglycerides ≥150 mg/dl. MAIN RESULTS AND THE ROLE OF CHANCE: There were 148 (12.3%) women with elevated total cholesterol, 94 (7.9%) with elevated LDL-C, 280 (23.2%) with elevated triglycerides and 606 (50.7%) with low HDL-C. The fecundability odds ratio (FOR) was reduced for all abnormal lipids before and after confounder adjustment, indicating reduced fecundability. Total cholesterol ≥200 mg/dl was associated with 24% (FOR: 0.76, 95% CI: 0.59, 0.97) and 29% (FOR: 0.71, 95% CI: 0.55, 0.93) reduced fecundability for hCG-detected and ultrasound-confirmed pregnancy, respectively, compared with total cholesterol <200 mg/dl. There was a 19-36% decrease in the probability of conception per cycle for women with abnormal lipoprotein levels, though additional adjustment for central adiposity and BMI attenuated observed associations. LIMITATIONS, REASONS FOR CAUTION: Although the FOR is a measure of couple fecundability, we had only measures of female lipid levels and can therefore not confirm the findings from a previous study indicating the independent role of male lipids in fecundity. The attenuated estimates and decreased precision after adjustment for central adiposity and obesity indicate the complexity of potential causal lipid pathways, suggesting other factors related to obesity besides dyslipidemia likely contribute to reduced fecundability. WIDER IMPLICATIONS OF THE FINDINGS: Our results are consistent with one other study relating preconception lipid concentrations to fecundity and expand these findings by adding critically important information about individual lipoproteins. As lipid levels are modifiable they may offer an inexpensive target to improve female fecundability. STUDY FUNDING AND COMPETING INTEREST(S): This study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The authors have declared that no conflicts of interest exist. TRIAL REGISTRATION NUMBER: #NCT00467363.
引用
- Pugh SJ, Schisterman EF, Browne RW, et al. Preconception maternal lipoprotein levels in relation to fecundability. Hum Reprod. 2017. PMID: 28333301. doi:10.1093/humrep/dex052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。